Spark Investment Management LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 76 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q1 2020$216,000
-47.8%
51,500
-51.1%
0.12%
+134.7%
Q4 2019$414,000
-67.2%
105,400
-26.6%
0.05%
-69.8%
Q3 2019$1,263,000
-40.7%
143,600
-37.7%
0.16%
+9.5%
Q2 2019$2,130,000
-13.9%
230,364
-40.2%
0.15%
+28.7%
Q1 2019$2,475,000
+113.5%
384,917
+213.0%
0.12%
+43.8%
Q4 2018$1,159,000
+286.3%
122,995
+342.4%
0.08%
+70.2%
Q1 2014$300,00027,8000.05%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2019
NameSharesValueWeighting ↓
TANG KEVIN C 240,000$1,027,00095.09%
TANG CAPITAL MANAGEMENT LLC 10,049,224$43,011,0008.56%
RTW INVESTMENTS, LP 2,327,903$9,963,0000.15%
Boxer Capital, LLC 890,700$3,812,0000.13%
Tibra Equities Europe Ltd 72,600$311,0000.10%
WealthTrust Axiom LLC 25,400$108,0000.04%
GSA CAPITAL PARTNERS LLP 52,749$226,0000.02%
FIRST MIDWEST BANK TRUST DIVISION 34,231$147,0000.02%
HOLLENCREST CAPITAL MANAGEMENT 42,355$181,0000.02%
Summit Global Investments 48,500$208,0000.01%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders